2014 saw the emergence of a novel rheumatoid arthritis therapy to rival 
methotrexate, as well as advances in our understanding of mouse T.cell biology 
and of the cross-talk between the nervous system and the immune system. How will 
these advances affect the future of rheumatoid arthritis research and therapy?
